Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT01181960
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with schizophrenia or bipolar I disorder
* Antipsychotic use in one of the following categories: Clinician ordered initiation of Risperidone long acting injectable in the 4 weeks prior to or on the day of enrollment (includes patients not previously on any antipsychotic medication and those switched from another antipsychotic)
* On continuous Risperidone long acting injectable for at least 6 months prior to enrollment (no gaps between injections\>30 days)
* Clinician ordered initiation of Paliperidone Palmitate in the 4 weeks prior to or on the day of enrollment (includes patients not previously on any antipsychotic medication and those switched from another antipsychotic)
* or on continuous Paliperidone Palmitate for any time period prior to enrollment
* Clinician ordered initiation of another antipsychotic in the 4 weeks prior to or on the day of enrollment (includes patients not previously on any antipsychotic medication and those switched from another antipsychotic)
* Not enrolled in another clinical study
* Primary source of care for schizophrenia or bipolar I disorder is the recruiting CBHO
* Agrees to all study procedures/interviews
* must sign the study informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
Exclusion Criteria:
* Currently participating in a clinical study (e.g. clinical trial or observational study) or participated in a clinical study within the past 30 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT01181960
Study Brief:
Protocol Section:
NCT01181960